Clinical trial
A Phase II Safety Study of TAK-375 in Subjects With Mild to Moderate Obstructive Sleep Apnea
NCT00672061 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Safety Study of TAK-375 in Subjects With Mild to Moderate Obstructive Sleep Apnea
- Lead sponsor
- Takeda
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- July 31, 2003
- Completion date
- December 31, 2003
- Enrollment
- 26 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.